Aviva’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-363,032
Closed -$690K 888
2024
Q2
$690K Buy
363,032
+217,614
+150% +$413K ﹤0.01% 679
2024
Q1
$413K Buy
+145,418
New +$413K ﹤0.01% 894